ChemicalBook > CAS DataBase List > AZD3514

AZD3514

Product Name
AZD3514
CAS No.
1240299-33-5
Chemical Name
AZD3514
Synonyms
CS-795;AZD3514;AZD3514 ,S7040;AZD3514 USP/EP/BP;AZD 3514; AZD-3514;AZD3514, 10 mM in DMSO;AZD3514;AZD-3514;AZD 3514;Baicalein 7-O-β-D-glucuronide;1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-;1-[4-[2-[4-[1-[7,8-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]-ethanone
CBNumber
CB32627358
Molecular Formula
C25H32F3N7O2
Formula Weight
519.56
MOL File
1240299-33-5.mol
More
Less

AZD3514 Property

Boiling point:
669.5±65.0 °C(Predicted)
Density 
1.41±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
≥24.45 mg/mL in DMSO; insoluble in H2O; ≥46.4 mg/mL in EtOH
form 
solid
pka
6.31±0.10(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H301Toxic if swalloed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P321Specific treatment (see … on this label).

P330Rinse mouth.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
378280
Product name
AZD-3514
Packaging
10mg
Price
$460
Updated
2021/12/16
ApexBio Technology
Product number
A1372
Product name
AZD3514
Packaging
10mM(in 1mL DMSO)
Price
$90
Updated
2021/12/16
ApexBio Technology
Product number
A1372
Product name
AZD3514
Packaging
10mg
Price
$120
Updated
2021/12/16
ApexBio Technology
Product number
A1372
Product name
AZD3514
Packaging
50mg
Price
$330
Updated
2021/12/16
ApexBio Technology
Product number
A1372
Product name
AZD3514
Packaging
100mg
Price
$540
Updated
2021/12/16
More
Less

AZD3514 Chemical Properties,Usage,Production

Uses

AZD3514 is an orally activie and selective androgen receptor (AR) inhibitor. AZD3514 androgen-dependently and -independently inhibits AR signal. AZD351 down-regulates nuclear AR levels in human LNCaP prostate cancer cells in the absence of androgen with an pIC50 value of 5.75. AZD3514 can be used for the research of prostate cancer[1][2][3].

in vivo

AZD3514 (10-100 mg/kg; p.o. once daily for 6 days) inhibits AR signaling in rats[2]. AZD3514 (50 mg/kg; p.o. once daily for 30 days) inhibits prostate tumor growth[2]. AZD3514 (50-100 mg/kg; p.o. once daily for 3 days) significantly reduces nuclear AR protein in vivo[2].

Animal Model:Intact or castrat 42- and 49-day-old Hans Wistar rats[2]
Dosage:10, 50 and 100 mg/kg
Administration:Oral gavage; 10-100 mg/kg once daily; for 6 days
Result:Inhibited AR signaling in rats, reduced seminal vesicle weight in intact rats, and inhibited the ability of exogenous testosterone proprionate to cause an increase in seminal vesicle weight in castrated rat.
Animal Model:Male Copenhagen rats with Dunning R3327H prostate tumors[2]
Dosage:50 mg/kg
Administration:Oral gavage; 50 mg/kg once daily; for 30 days
Result:Significantly inhibited prostate tumor growth of rats.

target

androgen receptor

References

[1] Bradbury RH, et al. Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1945-8. DOI:10.1016/j.bmcl.2013.02.056
[2] Loddick SA, et al. AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo. Mol Cancer Ther. 2013 Sep;12(9):1715-27. DOI:10.1158/1535-7163.MCT-12-1174
[3] Omlin A, et al. AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. Invest New Drugs. 2015 Jun;33(3):679-90. DOI:10.1007/s10637-015-0235-5

AZD3514 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

AZD3514 Suppliers

BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
12952
Advantage
65
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
United States Biological
Tel
--
Fax
--
Email
sales@advtechind.com
Country
United States
ProdList
6075
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
Creative Enzymes
Tel
--
Fax
--
Email
info@creative-enzymes.com
Country
United States
ProdList
6057
Advantage
58
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80

1240299-33-5, AZD3514Related Search:


  • AZD3514
  • 1-[4-[2-[4-[1-[7,8-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]-ethanone
  • Ethanone, 1-[4-[2-[4-[1-[7,8-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]-
  • 1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone
  • AZD3514;AZD-3514;AZD 3514
  • 1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-
  • AZD 3514; AZD-3514
  • CS-795
  • AZD3514 USP/EP/BP
  • Baicalein 7-O-β-D-glucuronide
  • 1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethan-1-one
  • AZD3514, 10 mM in DMSO
  • AZD3514 ,S7040
  • 1240299-33-5
  • C25H32F3N7O2
  • Inhibitors